{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:10:06Z","timestamp":1791774606628,"version":"4.3.4"},"reference-count":138,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.autrev.2021.102759","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T22:30:40Z","timestamp":1611009040000},"page":"102759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies"],"prefix":"10.1016","volume":"20","author":[{"given":"Giacomo","family":"Ramponi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Folci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G.M.C.","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Brunetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102759_bb0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1398-9995.1980.tb01768.x","article-title":"Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis","volume":"35","author":"Wiik","year":"1980","journal-title":"Allergy"},{"key":"10.1016\/j.autrev.2021.102759_bb0010","doi-asserted-by":"crossref","first-page":"i8","DOI":"10.1093\/ndt\/gfv070","article-title":"A historical essay on detection of anti-neutrophil cytoplasmic antibodies","volume":"30","author":"Rasmussen","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2021.102759_bb0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","article-title":"Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?","volume":"285","author":"Davies","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2021.102759_bb0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener\u2019s granulomatosis","volume":"1","author":"van der Woude","year":"1985","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.autrev.2021.102759_bb0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.30286","article-title":"Granulomatosis with polyangiitis (wegener\u2019s): An alternative name for wegener\u2019s granulomatosis","volume":"63","author":"Falk","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102759_bb0030","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/art.30481","article-title":"New etiopathogenic knowledge, or politics? Comment on the article by Falk et al","volume":"63","author":"Bacon","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102759_bb0035","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"NEJM"},{"key":"10.1016\/j.autrev.2021.102759_bb0040","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V75.11.2263.2263","article-title":"Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3","volume":"75","author":"Jennette","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102759_bb0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10067-018-4062-x","article-title":"Anti-neutrophil cytoplasmic antibodies and their clinical significance","volume":"37","author":"Suwanchote","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0050","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.autrev.2016.07.016","article-title":"The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)","volume":"15","author":"Weiner","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0055","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10157-013-0869-6","article-title":"Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"17","author":"Jennette","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.autrev.2021.102759_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000500544","article-title":"Anti-neutrophil cytoplasmic antibodies positivity and anti-leukotrienes in eosinophilic granulomatosis with polyangiitis: a retrospective monocentric study on 134 Italian patients","volume":"180","author":"Schroeder","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0065","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202005-1628SO","article-title":"International consensus on ANCA testing in eosinophilic granulomatosis with polyangiitis","author":"Moiseev","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl","key":"10.1016\/j.autrev.2021.102759_bb0070","first-page":"29","article-title":"Development and standardization of solid-phase assays for the detection of antineutrophil cytoplasmic antibodies (ANCA) for clinical application: report of a large clinical evaluation study","volume":"101","author":"Hagen","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(96)00111-1","article-title":"Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays","volume":"196","author":"Hagen","year":"1996","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2021.102759_bb0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","article-title":"International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)","volume":"111","author":"Savige","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2021.102759_bb0085","first-page":"1584","article-title":"Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies","volume":"28","author":"Choi","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0090","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102759_bb0095","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102759_bb0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102759_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102759_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/08916930400022673","article-title":"Antineutrophil cytoplasmic antibodies (ANCA)","volume":"38","author":"Radice","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2021.102759_bb0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/oxfordjournals.ndt.a092181","article-title":"Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"7","author":"O\u2019Donoghue","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2021.102759_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/clin.1994.1165","article-title":"Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Sch\u00f6nlein purpura and IgA nephropathy","volume":"73","author":"Sinico","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2021.102759_bb0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cei.12769","article-title":"IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis","volume":"184","author":"Sandin","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.1991.tb05647.x","article-title":"Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener\u2019s granulomatosis and clinically related disorders","volume":"83","author":"Brouwer","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.1995.tb08343.x","article-title":"Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener\u2019s granulomatosis: a predominant role for the IgG3 subclass of ANCA","volume":"101","author":"Mulder","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0145","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102759_bb0150","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome","volume":"16","author":"Danlos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0155","first-page":"1147","article-title":"No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study","author":"Yoo","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2016.12.004","article-title":"Germinal centers: programmed for affinity maturation and antibody diversification","volume":"45","author":"Bannard","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.genet.41.110306.130340","article-title":"Immunoglobulin somatic hypermutation","volume":"41","author":"Teng","year":"2007","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.autrev.2021.102759_bb0170","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/rheumatology\/ker085","article-title":"Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis","volume":"50","author":"Xu","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.102759_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cei.12796","article-title":"The avidity of PR3-ANCA in patients with granulomatosis with polyangiitis during follow-up","volume":"185","author":"Kemna","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0180","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ndt\/gft416","article-title":"Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody","volume":"29","author":"Land","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2021.102759_bb0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-444-63269-2.00003-9","article-title":"Epitope spreading in autoimmune diseases","author":"Venkatesha","year":"2015","journal-title":"Infect Autoimmun"},{"key":"10.1016\/j.autrev.2021.102759_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03453.x","article-title":"Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA)","volume":"150","author":"Talor","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0272-6386(95)90489-1","article-title":"Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis","volume":"26","author":"Short","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2021.102759_bb0200","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.01380217","article-title":"Anti-glomerular basement membrane disease","volume":"12","author":"Mcadoo","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102759_bb0205","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2215\/CJN.05270515","article-title":"Autoantibodies against linear epitopes of myeloperoxidase in anti\u2013glomerular basement membrane disease","volume":"11","author":"Li","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102759_bb0210","article-title":"Genetics of ANCA-associated vasculitides: HLA and beyond","volume":"32","author":"Alberici","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0215","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fimmu.2014.00577","article-title":"Genetic susceptibility to ANCA-associated vasculitis: state of the Art","volume":"5","author":"Bonatti","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.87.5.499","article-title":"The beginnings of immunofluorescence","volume":"87","author":"Coons","year":"1961","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0225","series-title":"Curr. Protoc. Cell Biol","first-page":"4.3.1","article-title":"Immunofluorescence staining","volume":"vol. 69","author":"Donaldson","year":"2015"},{"key":"10.1016\/j.autrev.2021.102759_bb0230","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","article-title":"Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0235","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cll.2019.07.005","article-title":"Diagnostic Pitfalls in Immunology Testing","volume":"39","author":"Maher","year":"2019","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.autrev.2021.102759_bb0240","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/jcp.51.8.568","article-title":"A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies","volume":"51","author":"Savige","year":"1998","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2021.102759_bb0245","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.autrev.2015.10.007","article-title":"Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15years","volume":"15","author":"Selmi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0250","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI114335","article-title":"Wegener\u2019s granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils","volume":"84","author":"Goldschmeding","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.102759_bb0255","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2249.1994.tb06051.x","article-title":"Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern","volume":"96","author":"Segelmark","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0260","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)91761-A","article-title":"Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy","volume":"342","author":"Dolman","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102759_bb0265","first-page":"775","article-title":"Antigen specificity in hydralazine associated ANCA positive systemic vasculitis","volume":"88","author":"Short","year":"1995","journal-title":"QJM An Int J Med"},{"key":"10.1016\/j.autrev.2021.102759_bb0270","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8088-8","article-title":"Atypical p-ANCA in PSC and AIH: A hint toward a \u201cleaky gut\u201d?","volume":"36","author":"Terjung","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0275","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/ard.2009.109868","article-title":"Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3","volume":"69","author":"Holle","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102759_bb0280","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrrheum.2014.78","article-title":"Current and emerging techniques for ANCA detection in vasculitis","volume":"10","author":"Csernok","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0285","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/annrheumdis-2016-209507","article-title":"Detection of antineutrophil cytoplasmic antibodies (ANCAs): A multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays","volume":"76","author":"Damoiseaux","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102759_bb0290","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.lpm.2013.01.028","article-title":"L28. Relevance of detection techniques for ANCA testing","volume":"42","author":"Csernok","year":"2013","journal-title":"Press Medicale"},{"key":"10.1016\/j.autrev.2021.102759_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107743","article-title":"Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA","volume":"9","author":"Sowa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102759_bb0300","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)69114-9","article-title":"Antineutrophil cytoplasmic antibodies","volume":"368","author":"Bosch","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102759_bb0305","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.autrev.2017.12.002","article-title":"Cellular immune regulation in the pathogenesis of ANCA-associated vasculitides","volume":"17","author":"von Borstel","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0310","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","article-title":"Autoimmunity is triggered by cPR-3(105\u2013201), a protein complementary to human autoantigen proteinase-3","volume":"10","author":"Pendergraft","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2021.102759_bb0315","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2021.102759_bb0320","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2249.1994.tb06578.x","article-title":"Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody","volume":"97","author":"Pudifin","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0325","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0330","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002564","article-title":"Antineutrophil cytoplasmic antibodies associated with infective endocarditis","volume":"95","author":"Langlois","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2021.102759_bb0335","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1084\/jem.184.6.2231","article-title":"Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming","volume":"184","author":"Gilligan","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2021.102759_bb0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2249.2000.01228.x","article-title":"Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils","volume":"121","author":"Yang","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/clim.2002.5194","article-title":"Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes","volume":"103","author":"Rauova","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0350","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1681\/ASN.V1281764","article-title":"Rats injected with syngenic rat apoptotic neutrophils develop antineutrophil cytoplasmic antibodies","volume":"12","author":"Patry","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102759_bb0355","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/art.11130","article-title":"Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis","volume":"48","author":"Clayton","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102759_bb0360","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science (80-)"},{"key":"10.1016\/j.autrev.2021.102759_bb0365","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2012-03-416156","article-title":"Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity","volume":"120","author":"Sangaletti","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102759_bb0370","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2021.102759_bb0375","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.autrev.2019.06.011","article-title":"An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment","volume":"18","author":"Frangou","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0380","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.102759_bb0385","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2249.1994.tb06518.x","article-title":"Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo","volume":"95","author":"Csernok","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0390","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.153.3.1271","article-title":"Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa","volume":"153","author":"Porges","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0395","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V98.5.1448","article-title":"Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation","volume":"98","author":"Ben-Smith","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102759_bb0400","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.1994.tb06137.x","article-title":"Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): A Fc\u03b3RII-dependent process","volume":"98","author":"Mulder","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0405","first-page":"609","article-title":"Proinflammatory genes expression in granulocytes activated by native proteinase-binding fragments of anti-proteinase 3 IgG","volume":"66","author":"Surmiak","year":"2015","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.autrev.2021.102759_bb0410","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/1529-0131(200112)44:12<2851::AID-ART473>3.0.CO;2-2","article-title":"Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells","volume":"44","author":"Radford","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102759_bb0415","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2005-03-0921","article-title":"Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo","volume":"106","author":"Little","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102759_bb0420","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.102759_bb0425","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","article-title":"The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies","volume":"167","author":"Xiao","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2021.102759_bb0430","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102759_bb0435","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2021.102759_bb0440","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/ard.2006.064626","article-title":"Rats and mice immunised with chimeric human\/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes","volume":"66","author":"van der Geld","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102759_bb0445","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/ndt\/gfv288","article-title":"Complement in ANCA-associated glomerulonephritis","volume":"32","author":"Hilhorst","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2021.102759_bb0450","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2353\/ajpath.2009.090533","article-title":"Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: An update","volume":"175","author":"G\u00f3mez-Puerta","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2021.102759_bb0455","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1189\/jlb.3MR0217-069R","article-title":"Proteinase 3: the odd one out that became an autoantigen","volume":"102","author":"Martin","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2021.102759_bb0460","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/rheumatology\/kez111","article-title":"PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules","volume":"58","author":"Gregersen","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.102759_bb0465","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","article-title":"ANCA-associated vasculitis \u2014 clinical utility of using ANCA specificity to classify patients","volume":"12","author":"Cornec","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0470","first-page":"603","article-title":"Prevalence of ANCA in a hospitalized elderly French population","volume":"15","author":"Maillefert","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0475","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autrev.2017.11.014","article-title":"Childhood- versus adult-onset ANCA-associated vasculitides: A nested, matched case\u2013control study from the French Vasculitis Study Group Registry","volume":"17","author":"Iudici","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0480","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q","article-title":"Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions","volume":"13","author":"Stone","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2021.102759_bb0485","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/qjmed\/94.11.615","article-title":"The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting","volume":"94","author":"McLaren","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2021.102759_bb0490","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/rheumatology\/40.2.178","article-title":"Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA","volume":"40","author":"Sch\u00f6nermarck","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102759_bb0495","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1874312900903010014","article-title":"ANCA-positive patients: the influence of PR3 and MPO antibodies on survival rate and the association with clinical and laboratory characteristics","volume":"3","author":"Drooger","year":"2009","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.autrev.2021.102759_bb0500","first-page":"626495","article-title":"Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients","volume":"2011","author":"Tsiveriotis","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.autrev.2021.102759_bb0505","article-title":"The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis","volume":"102716","author":"Guchelaar","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0510","first-page":"36","article-title":"Spectrum of ANCA-associated disorders according to serological phenotype in routine care: retrospective case series of 209 patients","volume":"1","author":"Debard","year":"2013","journal-title":"J Autoimmune Dis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0515","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00296-017-3905-0","article-title":"Diagnostic outcome and indications for testing in patients with positive ANCA at a Canadian tertiary care centre","volume":"38","author":"Chehroudi","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2021.102759_bb0520","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.2010.198","article-title":"Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals","volume":"78","author":"Cui","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2021.102759_bb0525","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pathol.2016.03.014","article-title":"Low level autoantibodies can be frequently detected in the general Australian population","volume":"48","author":"Deshpande","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.autrev.2021.102759_bb0530","doi-asserted-by":"crossref","first-page":"102495","DOI":"10.1016\/j.autrev.2020.102495","article-title":"Clinical associations of renal involvement in ANCA-associated vasculitis","volume":"19","author":"Kronbichler","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0535","doi-asserted-by":"crossref","first-page":"102642","DOI":"10.1016\/j.autrev.2020.102642","article-title":"Characteristics and prognosis of ANCA-positive retroperitoneal fibrosis: A systematic literature review","volume":"19","author":"Akiyama","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0540","article-title":"Comorbidities and health-related quality of life in Patients with Antineutrophil Cytoplasmic Antibody (ANCA) - associated vasculitis","volume":"102708","author":"Mercuzot","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0545","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2019.03.001","article-title":"Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients","volume":"18","author":"P\u00e9rez-Jacoiste As\u00edn","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0550","first-page":"58","article-title":"110.classification criteria for the anca-associated vasculitides","author":"Robson","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.102759_bb0555","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.181.2.585","article-title":"A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cell","volume":"181","author":"Kain","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2021.102759_bb0560","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","article-title":"Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis","volume":"14","author":"Kain","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2021.102759_bb0565","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.2011030273","article-title":"Anti\u2013LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis","volume":"23","author":"Roth","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102759_bb0570","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1681\/ASN.2013030320","article-title":"Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN","volume":"25","author":"Peschel","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102759_bb0575","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.102759_bb0580","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: Useful in patients with renal involvement but not in patients with nonrenal disease","volume":"26","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102759_bb0585","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12016-012-8320-4","article-title":"Antineutrophil cytoplasmic autoantibodies: How are they detected and what is their use for diagnosis, classification and follow-up?","volume":"43","author":"Tervaert","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0590","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1074\/jbc.M112.418970","article-title":"Ceruloplasmin is an endogenous inhibitor of myeloperoxidase","volume":"288","author":"Chapman","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.102759_bb0595","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","article-title":"Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.102759_bb0600","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","article-title":"Trojan horses","volume":"26","author":"Pendergraft","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0605","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.autrev.2017.11.011","article-title":"Cocaine and ANCA associated vasculitis-like syndromes \u2013 A case series","volume":"17","author":"Subesinghe","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102759_bb0610","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1797.2009.01100.x","article-title":"Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"14","author":"GAO","year":"2009","journal-title":"Nephrology"},{"key":"10.1016\/j.autrev.2021.102759_bb0615","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2215\/CJN.03440411","article-title":"Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease","volume":"6","author":"McGrath","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2021.102759_bb0620","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/02791072.2014.959215","article-title":"Levamisole-adulterated cocaine: what about in european countries?","volume":"46","author":"Eiden","year":"2014","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.autrev.2021.102759_bb0625","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11926-017-0653-9","article-title":"Cocaine-Levamisole-induced vasculitis\/vasculopathy syndrome","volume":"19","author":"Marquez","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2021.102759_bb0630","article-title":"Atypical chronic inflammatory ANCA-positive deforming arthritis after cocaine-levamisole exposure","volume":"1","author":"Emil","year":"2018","journal-title":"JCR J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102759_bb0635","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2021.102759_bb0640","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcp\/99.3.277","article-title":"Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: high prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis","volume":"99","author":"Hardarson","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2021.102759_bb0645","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/gut.34.1.56","article-title":"Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn\u2019s disease","volume":"34","author":"Peen","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2021.102759_bb0650","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role","volume":"42","author":"Quinton","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2021.102759_bb0655","first-page":"826","article-title":"Diagnosis and treatment of indeterminate colitis","volume":"7","author":"Tremaine","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.autrev.2021.102759_bb0660","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1373\/clinchem.2005.058560","article-title":"Serologic markers in inflammatory bowel disease","volume":"52","author":"Bossuyt","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2021.102759_bb0665","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.3748\/wjg.14.7012","article-title":"A subset of ulcerative colitis with positive proteinase-3 antineutrophil cytoplasmic antibody","volume":"14","author":"Xu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2021.102759_bb0670","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12016-012-8349-4","article-title":"Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel Disease","volume":"45","author":"Arias-Loste","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2021.102759_bb0675","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cca.2013.06.005","article-title":"PR3-ANCA: A promising biomarker for ulcerative colitis with extensive disease","volume":"424","author":"Mahler","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2021.102759_bb0680","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1515\/cclm-2017-0346","article-title":"PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis","volume":"56","author":"Mahler","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2021.102759_bb0685","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1097\/MIB.0000000000000903","article-title":"New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes","volume":"22","author":"Barnes","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2021.102759_bb0690","doi-asserted-by":"crossref","first-page":"102618","DOI":"10.1016\/j.autrev.2020.102618","article-title":"2020 international consensus on ANCA testing beyond systemic vasculitis","volume":"19","author":"Moiseev","year":"2020","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:21:56Z","timestamp":1761600116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":138,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1568997221000185"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102759","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102759"}}